Rhodei-litorin [6767]



Rhodei-litorin


SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)O
InChIKey SVUYIHOQEOWECO-SRURJFDISA-N
Sequence QLWATGHFM
HELM PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].[*C(=O)C(C(C)CC)N* |$_R2;;;;;;;;;_R1$|].(W,[dW]).(A,[dA]).[*C(=O)C(C(C)O)N* |$_R2;;;;;;;;_R1$|].G.(H,[dH]).(F,[dF]).(M,[dM]).[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 14
Rotatable bonds 32
Log P -1.694
Molecular weight (Da) 1089.5
Stereochemistry info partial

Database connections

Model (AF2) BB1 BB2


No bioactivity data available.

Rhodei-litorin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) BB1 BB2


Compound is not listed as a drug.